Enliven Therapeutics, Inc. Insider Transactions
Enliven Therapeutics, Inc. Insider Trades History
| Insider Name | Buy/Sell | Shares Bought/Sold @ Price |
Total Transaction | Shares Held After Transaction |
Transaction Date | Filing Date | Details |
|---|---|---|---|---|---|---|---|
|
Ballal Rahul D.
Director |
Sell | 10,420 @ $28.17 | $293.56 K | 22,341 | 10/08/2024 | 10/10/2024 | |
|
Hohl Benjamin
CHIEF FINANCIAL OFFICER |
Sell | 1,270 @ $27.51 | $34.94 K | 0 | 10/07/2024 | 10/08/2024 | |
|
Kintz Samuel
CEO |
Sell | 2,730 @ $27.50 | $75.08 K | 1,033,793 | 10/07/2024 | 10/08/2024 | |
|
Lyssikatos Joseph P
CHIEF SCIENTIFIC OFFICER |
Sell | 2,707 @ $27.61 | $74.73 K | 1,067,180 | 10/07/2024 | 10/08/2024 | |
|
Hohl Benjamin
CHIEF FINANCIAL OFFICER |
Sell | 10,218 @ $27.51 | $281.08 K | 0 | 10/04/2024 | 10/08/2024 | |
|
Heyman Richard A.
Director |
Sell | 2,825 @ $27.51 | $77.70 K | 125,760 | 10/04/2024 | 10/08/2024 | |
|
Kintz Samuel
CEO |
Sell | 12,206 @ $27.51 | $335.79 K | 1,036,523 | 10/04/2024 | 10/08/2024 | |
|
Lyssikatos Joseph P
CHIEF SCIENTIFIC OFFICER |
Sell | 7,522 @ $27.51 | $206.94 K | 1,069,887 | 10/04/2024 | 10/08/2024 | |
|
Lyssikatos Joseph P
CHIEF SCIENTIFIC OFFICER |
Sell | 527 @ $27.54 | $14.51 K | 1,077,409 | 10/01/2024 | 10/03/2024 | |
|
Kintz Samuel
CEO |
Sell | 526 @ $27.54 | $14.49 K | 1,048,729 | 10/01/2024 | 10/03/2024 | |
|
Hohl Benjamin
CHIEF FINANCIAL OFFICER |
Sell | 521 @ $27.54 | $14.35 K | 0 | 10/01/2024 | 10/03/2024 |
Enliven Therapeutics, Inc. FAQ's
The list of insiders at Enliven Therapeutics, Inc. includes Hohl Benjamin, Patel Anish, Kintz Samuel, Lyssikatos Joseph P.
Insiders have sold a total of 95.37 K Enliven Therapeutics, Inc. shares in the last 12 months for a total of 2.07 M sold.
The following insiders have sold Enliven Therapeutics, Inc. shares in the last 12 months: Hohl Benjamin ($370.37 K), Patel Anish ($1.10 M), Kintz Samuel ($342.42 K), Lyssikatos Joseph P ($257.58 K),